Index
1 Choroidal Neovascularization Market Overview
1.1 Product Overview and Scope of Choroidal Neovascularization
1.2 Choroidal Neovascularization Segment by Type
1.2.1 Global Choroidal Neovascularization Market Value Comparison by Type (2024-2030)
1.2.2 Intravenous
1.2.3 Intravitreal
1.3 Choroidal Neovascularization Segment by Application
1.3.1 Global Choroidal Neovascularization Market Value by Application: (2024-2030)
1.3.2 Extreme Myopia
1.3.3 Malignant Myopic Degeneration
1.3.4 Age-Related Developments
1.4 Global Choroidal Neovascularization Market Size Estimates and Forecasts
1.4.1 Global Choroidal Neovascularization Revenue 2019-2030
1.4.2 Global Choroidal Neovascularization Sales 2019-2030
1.4.3 Global Choroidal Neovascularization Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Choroidal Neovascularization Market Competition by Manufacturers
2.1 Global Choroidal Neovascularization Sales Market Share by Manufacturers (2019-2024)
2.2 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Choroidal Neovascularization Average Price by Manufacturers (2019-2024)
2.4 Global Choroidal Neovascularization Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Choroidal Neovascularization, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Choroidal Neovascularization, Product Type & Application
2.7 Choroidal Neovascularization Market Competitive Situation and Trends
2.7.1 Choroidal Neovascularization Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Choroidal Neovascularization Players Market Share by Revenue
2.7.3 Global Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Choroidal Neovascularization Retrospective Market Scenario by Region
3.1 Global Choroidal Neovascularization Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Choroidal Neovascularization Global Choroidal Neovascularization Sales by Region: 2019-2030
3.2.1 Global Choroidal Neovascularization Sales by Region: 2019-2024
3.2.2 Global Choroidal Neovascularization Sales by Region: 2025-2030
3.3 Global Choroidal Neovascularization Global Choroidal Neovascularization Revenue by Region: 2019-2030
3.3.1 Global Choroidal Neovascularization Revenue by Region: 2019-2024
3.3.2 Global Choroidal Neovascularization Revenue by Region: 2025-2030
3.4 North America Choroidal Neovascularization Market Facts & Figures by Country
3.4.1 North America Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Choroidal Neovascularization Sales by Country (2019-2030)
3.4.3 North America Choroidal Neovascularization Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Choroidal Neovascularization Market Facts & Figures by Country
3.5.1 Europe Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Choroidal Neovascularization Sales by Country (2019-2030)
3.5.3 Europe Choroidal Neovascularization Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Choroidal Neovascularization Market Facts & Figures by Country
3.6.1 Asia Pacific Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Choroidal Neovascularization Sales by Country (2019-2030)
3.6.3 Asia Pacific Choroidal Neovascularization Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Indonesia
3.6.10 Thailand
3.6.11 Malaysia
3.6.12 Philippines
3.6.13 Vietnam
3.7 Latin America Choroidal Neovascularization Market Facts & Figures by Country
3.7.1 Latin America Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Choroidal Neovascularization Sales by Country (2019-2030)
3.7.3 Latin America Choroidal Neovascularization Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Choroidal Neovascularization Market Facts & Figures by Country
3.8.1 Middle East and Africa Choroidal Neovascularization Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Choroidal Neovascularization Sales by Country (2019-2030)
3.8.3 Middle East and Africa Choroidal Neovascularization Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Choroidal Neovascularization Sales by Type (2019-2030)
4.1.1 Global Choroidal Neovascularization Sales by Type (2019-2024)
4.1.2 Global Choroidal Neovascularization Sales by Type (2025-2030)
4.1.3 Global Choroidal Neovascularization Sales Market Share by Type (2019-2030)
4.2 Global Choroidal Neovascularization Revenue by Type (2019-2030)
4.2.1 Global Choroidal Neovascularization Revenue by Type (2019-2024)
4.2.2 Global Choroidal Neovascularization Revenue by Type (2025-2030)
4.2.3 Global Choroidal Neovascularization Revenue Market Share by Type (2019-2030)
4.3 Global Choroidal Neovascularization Price by Type (2019-2030)
5 Segment by Application
5.1 Global Choroidal Neovascularization Sales by Application (2019-2030)
5.1.1 Global Choroidal Neovascularization Sales by Application (2019-2024)
5.1.2 Global Choroidal Neovascularization Sales by Application (2025-2030)
5.1.3 Global Choroidal Neovascularization Sales Market Share by Application (2019-2030)
5.2 Global Choroidal Neovascularization Revenue by Application (2019-2030)
5.2.1 Global Choroidal Neovascularization Revenue by Application (2019-2024)
5.2.2 Global Choroidal Neovascularization Revenue by Application (2025-2030)
5.2.3 Global Choroidal Neovascularization Revenue Market Share by Application (2019-2030)
5.3 Global Choroidal Neovascularization Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Inc. Choroidal Neovascularization Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.2.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.2.4 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Portfolio
6.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis AG Choroidal Neovascularization Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Regeneron Pharmaceuticals Inc.
6.4.1 Regeneron Pharmaceuticals Inc. Corporation Information
6.4.2 Regeneron Pharmaceuticals Inc. Description and Business Overview
6.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Portfolio
6.4.5 Regeneron Pharmaceuticals Inc. Recent Developments/Updates
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Description and Business Overview
6.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer AG Choroidal Neovascularization Product Portfolio
6.5.5 Bayer AG Recent Developments/Updates
6.6 QLT Inc.
6.6.1 QLT Inc. Corporation Information
6.6.2 QLT Inc. Description and Business Overview
6.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.6.4 QLT Inc. Choroidal Neovascularization Product Portfolio
6.6.5 QLT Inc. Recent Developments/Updates
6.7 Sanwa Kagaku Kenkyusho Co. Ltd.
6.6.1 Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
6.6.2 Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview
6.6.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Portfolio
6.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
6.8 Promedior Inc.
6.8.1 Promedior Inc. Corporation Information
6.8.2 Promedior Inc. Description and Business Overview
6.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Promedior Inc. Choroidal Neovascularization Product Portfolio
6.8.5 Promedior Inc. Recent Developments/Updates
6.9 Bausch Health
6.9.1 Bausch Health Corporation Information
6.9.2 Bausch Health Description and Business Overview
6.9.3 Bausch Health Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bausch Health Choroidal Neovascularization Product Portfolio
6.9.5 Bausch Health Recent Developments/Updates
6.10 Gilead Sciences Inc
6.10.1 Gilead Sciences Inc Corporation Information
6.10.2 Gilead Sciences Inc Description and Business Overview
6.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Gilead Sciences Inc Choroidal Neovascularization Product Portfolio
6.10.5 Gilead Sciences Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Choroidal Neovascularization Industry Chain Analysis
7.2 Choroidal Neovascularization Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Choroidal Neovascularization Production Mode & Process
7.4 Choroidal Neovascularization Sales and Marketing
7.4.1 Choroidal Neovascularization Sales Channels
7.4.2 Choroidal Neovascularization Distributors
7.5 Choroidal Neovascularization Customers
8 Choroidal Neovascularization Market Dynamics
8.1 Choroidal Neovascularization Industry Trends
8.2 Choroidal Neovascularization Market Drivers
8.3 Choroidal Neovascularization Market Challenges
8.4 Choroidal Neovascularization Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer